Anti-PD-1 in Combination With Chemotherapy as First-Line Treatment to Lung Cancer
Clinical trial NCT03432598 · COMPLETED
Trial details
- NCT number
- NCT03432598
- Sponsor
- BeiGene
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-24
- Primary completion
- 2019-02-25
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.